A noninvasive neuromonitoring technology uses broadband near-infrared spectroscopy to measure concentrations of oxidized cytochrome c oxidase (oxCCO), a metabolic mitochondrial enzyme linked to Alzheimer’s disease. (IMAGE)

SPIE--International Society for Optics and Photonics

A noninvasive neuromonitoring technology uses broadband near-infrared spectroscopy to measure concentrations of oxidized cytochrome c oxidase (oxCCO), a metabolic mitochondrial enzyme linked to Alzheimer’s disease.

Caption

A noninvasive neuromonitoring technology uses broadband near-infrared spectroscopy to measure concentrations of oxidized cytochrome c oxidase (oxCCO), a metabolic mitochondrial enzyme linked to Alzheimer’s disease. A pilot study suggests this may be an effective portable technique for diagnosing and monitoring dementia. 

Credit

Image courtesy of D. Acharya et al. (University of Cambridge).

Usage Restrictions

For media use.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.